
The Teva-Cephalon deal remains under review by the US Federal Trade Commission and the European Commission. Teva Pharmaceuticals has sold the rights to three products to avoid a conflict related to its recent acquisition of Cephalon. ... Teva sells generic rights to Cephalon drugs to Par
No comments:
Post a Comment